Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
February 26, 2003
INTERNATIONAL IMMUNIZATION NEWS
"PowderJect Receives Canadian Approval for Cholera, Travel Vaccine, Dukoral" AFX News (www.afxpress.com) (02/25/03)
PowderJect Pharmaceuticals' cholera and travelers' diarrhea vaccine, Dukoral, has received regulatory approval from Canada. The drinkable vaccine, which protects against diarrhea caused by Vibrio cholerae and enterotoxigenic E. coli (ETEC), has been approved in 18 countries; it is still awaiting approval from European regulators. PowderJect CEO Paul Drayson points out that Dukoral is the only vaccine that can protect travelers against both cholera and ETEC.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.